Article Text

Download PDFPDF
Effect of 308 nm excimer laser irradiation on retinal pigment epithelium cell viability in vitro
  1. T U Krohne,
  2. S Hunt,
  3. F G Holz
  1. Department of Ophthalmology, University of Bonn, Bonn, Germany
  1. Dr T U Krohne, Department of Ophthalmology, University of Bonn, Ernst-Abbe-Str. 2, D-53127 Bonn, Germany; krohne{at}


Background: Translocation of an autologous retinal pigment epithelium (RPE) sheet under the macula is currently under investigation as a treatment for exudative AMD. Excimer laser-assisted RPE sheet translocation (EST) employs intraocular excimer ablation of excess graft choroidal tissue as a measure to enhance RPE sheet functionality. This study assessed potential adverse effects of excimer irradiation on RPE cells in vitro.

Methods: Human RPE cells (ARPE-19) received 308 nm XeCl excimer laser treatment or 311–312 nm UV-B irradiation. Cell death was visualised with Trypan Blue and quantified by LDH release assay. Apoptosis was detected by DNA fragmentation assay.

Results: Laser treatment of 0.175–0.25 J/cm2 resulted in delayed cell death within 48 h. Time course and dose response paralleled the effect of UV-B irradiation. Cytotoxicity was mediated by apoptosis. Human choroid/Bruch membrane tissue sheets covering the cells during laser irradiation reduced cytotoxicity by 87–95%.

Conclusion: Cultured human RPE cells are susceptible to apoptotic cell death induced by 308 nm excimer laser irradiation. Absorption by choroid/Bruch membrane tissue can largely prevent the cytotoxic effect. In clinical application, the residual adverse effect of laser ablation on graft RPE cell viability needs to be outweighed by potential advantageous effects on graft survival and functionality to allow for a sensible application of excimer ablation in RPE translocation surgery.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: FGH holds a patent on the surgical method of tissue removal by intraocular excimer laser ablation.